If people are looking for confirmation that the global cardiac rhythm management market has declined as much as it could and will fall no further, they have to wait a while. A week ago St. Jude Medical CEO Dan Starks admitted that the company has been routinely too optimistic in predicting the bottom of the market. Acknowledging that he was likely being conservative in providing financial guidance, Starks noted that St. Jude Medical has not seen the bottom of the CRM market and cannot provide a definitive statement on when it will stabilize.
